The H2S-Donor Erucin Exhibits Protective Effects against Vascular Inflammation in Human Endothelial and Smooth Muscle Cells

Preservation of vascular wall integrity against degenerative processes associated with ageing, fat-rich diet and metabolic diseases is a timely therapeutical challenge. The loss of endothelial function and integrity leads to cardiovascular diseases and multiorgan inflammation. The protective effects of the H2S-donor erucin, an isothiocyanate purified by Eruca sativa Mill. seeds, were evaluated on human endothelial and vascular smooth muscle cells. In particular, erucin actions were evaluated on cell viability, ROS, caspase 3/7, inflammatory markers levels and the endothelial hyperpermeability in an inflammatory model associated with high glucose concentrations (25 mM, HG). Erucin significantly prevented the HG-induced decrease in cell viability as well as the increase in ROS, caspase 3/7 activation, and TNF-α and IL-6 levels. Similarly, erucin suppressed COX-2 and NF-κB upregulation associated with HG exposure. Erucin also caused a significant inhibition of p22phox subunit expression in endothelial cells. In addition, erucin significantly prevented the HG-induced increase in endothelial permeability as also confirmed by the quantification of the specific markers VE-Cadherin and ZO-1. In conclusion, our results assess anti-inflammatory and antioxidant effects by erucin in vascular cells undergoing HG-induced inflammation and this protection parallels the preservation of endothelial barrier properties.

[1]  Meng Li,et al.  New therapeutic approaches using hydrogen sulfide donors in inflammation and immune-response. , 2021, Antioxidants & redox signaling.

[2]  M. Gonthier,et al.  Hyperglycemic Condition Causes Pro-Inflammatory and Permeability Alterations Associated with Monocyte Recruitment and Deregulated NFκB/PPARγ Pathways on Cerebral Endothelial Cells: Evidence for Polyphenols Uptake and Protective Effect , 2021, International journal of molecular sciences.

[3]  D. Creek,et al.  Sulforaphane Bioavailability and Effects on Blood Pressure in Women with Pregnancy Hypertension , 2021, Reproductive Sciences.

[4]  Simone Brogi,et al.  Role of hydrogen sulfide in endothelial dysfunction: Pathophysiology and therapeutic approaches , 2020, Journal of advanced research.

[5]  G. Caliendo,et al.  Structure-activity relationships study of isothiocyanates for H2S releasing properties: 3-Pyridyl-isothiocyanate as a new promising cardioprotective agent , 2020, Journal of advanced research.

[6]  V. Calderone,et al.  Recent efforts in drug discovery on vascular inflammation and consequent atherosclerosis , 2020, Expert opinion on drug discovery.

[7]  V. Calderone,et al.  Pharmacological modulation of the hydrogen sulfide (H2S) system by dietary H2S‐donors: A novel promising strategy in the prevention and treatment of type 2 diabetes mellitus , 2020, Phytotherapy research : PTR.

[8]  Hai-Jian Sun,et al.  Role of Endothelial Dysfunction in Cardiovascular Diseases: The Link Between Inflammation and Hydrogen Sulfide , 2020, Frontiers in Pharmacology.

[9]  Dejian Huang,et al.  Isothiocyanates as H2S Donors Triggered by Cysteine: Reaction Mechanism and Structure and Activity Relationship. , 2019, Organic letters.

[10]  C. Giannattasio,et al.  Vascular Aging and Disease of the Large Vessels: Role of Inflammation , 2019, High Blood Pressure & Cardiovascular Prevention.

[11]  L. Lazzeri,et al.  Erucin exhibits vasorelaxing effects and antihypertensive activity by H2S‐releasing properties , 2019, British journal of pharmacology.

[12]  L. Lazzeri,et al.  Anticancer properties of erucin, an H2S‐releasing isothiocyanate, on human pancreatic adenocarcinoma cells (AsPC‐1) , 2019, Phytotherapy research : PTR.

[13]  P. Møller,et al.  Anthocyanins and metabolites resolve TNF-α-mediated production of E-selectin and adhesion of monocytes to endothelial cells. , 2019, Chemico-biological interactions.

[14]  V. Calderone,et al.  Vascular Effects of H2S-Donors: Fluorimetric Detection of H2S Generation and Ion Channel Activation in Human Aortic Smooth Muscle Cells. , 2019, Methods in molecular biology.

[15]  A. Casola,et al.  Role of Hydrogen Sulfide in NRF2- and Sirtuin-Dependent Maintenance of Cellular Redox Balance , 2018, Antioxidants.

[16]  L. Morbidelli,et al.  The metal-nonoate Ni(SalPipNONO) inhibits in vitro tumor growth, invasiveness and angiogenesis , 2018, Oncotarget.

[17]  P. Maffia,et al.  Targeting inflammation to reduce cardiovascular disease risk , 2017, British journal of pharmacology.

[18]  Giuseppe Cirino,et al.  Nitric oxide and hydrogen sulfide: the gasotransmitter paradigm of the vascular system , 2017, British journal of pharmacology.

[19]  N. Sattar,et al.  Targeting inflammation to reduce cardiovascular disease risk: a realistic clinical prospect? , 2017, British journal of pharmacology.

[20]  L. Morbidelli,et al.  Efficacy of AdipoDren® in Reducing Interleukin-1-Induced Lymphatic Endothelial Hyperpermeability , 2016, Journal of Vascular Research.

[21]  Zhi-Sheng Jiang,et al.  Hydrogen sulfide suppresses angiotensin II-stimulated endothelin-1 generation and subsequent cytotoxicity-induced endoplasmic reticulum stress in endothelial cells via NF-κB. , 2016, Molecular medicine reports.

[22]  V. Calderone,et al.  The novel H2S donor 4‐carboxy‐phenyl isothiocyanate inhibits mast cell degranulation and renin release by decreasing intracellular calcium , 2016, British journal of pharmacology.

[23]  M. Breschi,et al.  Using hydrogen sulfide to design and develop drugs , 2016, Expert opinion on drug discovery.

[24]  M. W. Wong,et al.  Diallyl Trisulfide Is a Fast H2S Donor, but Diallyl Disulfide Is a Slow One: The Reaction Pathways and Intermediates of Glutathione with Polysulfides. , 2015, Organic letters.

[25]  Wenming Xu,et al.  Exogenous H2S protects H9c2 cardiac cells against high glucose-induced injury and inflammation by inhibiting the activation of the NF-κB and IL-1β pathways. , 2015, International journal of molecular medicine.

[26]  M. Perretti,et al.  Annexin A1 Mediates Hydrogen Sulfide Properties in the Control of Inflammation , 2014, The Journal of Pharmacology and Experimental Therapeutics.

[27]  R. Dixon,et al.  Disruption of endothelial adherens junctions by high glucose is mediated by protein kinase C-β–dependent vascular endothelial cadherin tyrosine phosphorylation , 2014, Cardiovascular Diabetology.

[28]  M. Breschi,et al.  Hydrogen Sulfide Releasing Capacity of Natural Isothiocyanates: Is It a Reliable Explanation for the Multiple Biological Effects of Brassicaceae? , 2014, Planta Medica.

[29]  Yu Zhao,et al.  Fluorescent probes based on nucleophilic substitution-cyclization for hydrogen sulfide detection and bioimaging. , 2014, Chemistry.

[30]  M. Breschi,et al.  Pharmacological characterization of the vascular effects of aryl isothiocyanates: is hydrogen sulfide the real player? , 2014, Vascular pharmacology.

[31]  V. Víctor,et al.  Human Leukocyte/Endothelial Cell Interactions and Mitochondrial Dysfunction in Type 2 Diabetic Patients and Their Association With Silent Myocardial Ischemia , 2013, Diabetes Care.

[32]  R. Keep,et al.  Protective effects of isothiocyanates on blood-CSF barrier disruption induced by oxidative stress. , 2012, American journal of physiology. Regulatory, integrative and comparative physiology.

[33]  David E. Williams,et al.  Metabolism and Tissue Distribution of Sulforaphane in Nrf2 Knockout and Wild-Type Mice , 2011, Pharmaceutical Research.

[34]  M. Traka,et al.  Biological Profile of Erucin: A New Promising Anticancer Agent from Cruciferous Vegetables , 2010, Toxins.

[35]  Robert W. Mills,et al.  Hydrogen sulfide mediates the vasoactivity of garlic , 2007, Proceedings of the National Academy of Sciences.

[36]  P. van Bladeren,et al.  Association between consumption of cruciferous vegetables and condiments and excretion in urine of isothiocyanate mercapturic acids. , 2006, Journal of agricultural and food chemistry.

[37]  R. Dietz,et al.  High glucose concentrations increase endothelial cell permeability via activation of protein kinase C alpha. , 1997, Circulation research.